<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>

<channel>
	<title>PR Hub &#187; Pennsylvania</title>
	<atom:link href="http://pr.gaeatimes.com/t/pennsylvania/feed/" rel="self" type="application/rss+xml" />
	<link>http://pr.gaeatimes.com</link>
	<description></description>
	<pubDate>Thu, 15 Dec 2011 05:00:00 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>INetU Achieves Worldwide PCI Certification in the Cloud for E-Commerce</title>
		<link>http://pr.gaeatimes.com/inetu-achieves-worldwide-pci-certification-in-the-cloud-for-e-commerce-54884/</link>
		<comments>http://pr.gaeatimes.com/inetu-achieves-worldwide-pci-certification-in-the-cloud-for-e-commerce-54884/#comments</comments>
		<pubDate>Thu, 15 Dec 2011 05:00:00 +0000</pubDate>
		<dc:creator>Inetu</dc:creator>
		
		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[High Tech Security]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Allentown]]></category>

		<category><![CDATA[December 15]]></category>

		<category><![CDATA[Inetu]]></category>

		<category><![CDATA[Netherlands]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[virginia]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/inetu-achieves-worldwide-pci-certification-in-the-cloud-for-e-commerce-54884/</guid>
		<description><![CDATA[ALLENTOWN, Pennsylvania, December 15, 2011  -

- Company&#8217;s PCI compliant Gated Community Cloud&#8482; provides e-commerce enterprises with a global Cloud offering certified and ready to do business
Leading managed hosting provider INetU, Inc (www.inetu.net) has announced that its exclusive &#8220;Gated Community Cloud&#8221; global business service has been certified PCI DSS compliant at its US and EU ... Read more : <a href="http://pr.gaeatimes.com/inetu-achieves-worldwide-pci-certification-in-the-cloud-for-e-commerce-54884/">INetU Achieves Worldwide PCI Certification in the Cloud for E-Commerce</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/inetu-achieves-worldwide-pci-certification-in-the-cloud-for-e-commerce-54884/feed/</wfw:commentRss>
		</item>
		<item>
		<title>ViroPharma&#8217;s Buccolam®▼ (Midazolam, Oromucosal Solution) now Available in the United Kingdom as Licenced Product for Emergency Treatment of Seizures in Children and Adolescents</title>
		<link>http://pr.gaeatimes.com/viropharmas-buccolam%c2%ae%e2%96%bc-midazolam-oromucosal-solution-now-available-in-the-united-kingdom-as-licenced-product-for-emergency-treatment-of-seizures-in-children-and-adolescents-54648/</link>
		<comments>http://pr.gaeatimes.com/viropharmas-buccolam%c2%ae%e2%96%bc-midazolam-oromucosal-solution-now-available-in-the-united-kingdom-as-licenced-product-for-emergency-treatment-of-seizures-in-children-and-adolescents-54648/#comments</comments>
		<pubDate>Mon, 12 Dec 2011 05:00:00 +0000</pubDate>
		<dc:creator>Viropharma Incorporated</dc:creator>
		
		<category><![CDATA[Children Related]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Multicultural]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[December 12]]></category>

		<category><![CDATA[Exton]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Viropharma Incorporated]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/viropharmas-buccolam%c2%ae%e2%96%bc-midazolam-oromucosal-solution-now-available-in-the-united-kingdom-as-licenced-product-for-emergency-treatment-of-seizures-in-children-and-adolescents-54648/</guid>
		<description><![CDATA[EXTON, Pennsylvania, December 12, 2011  -

Clinicians and carers of children and adolescents suffering from prolonged, acute, convulsive seizures now have access to Buccolam® (midazolam oromucosal solution), a newly approved rescue medication to treat prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents, from 3 months to less than 18 years of age.[1] For .... Source &nbsp;: <a href="http://pr.gaeatimes.com/viropharmas-buccolam%c2%ae%e2%96%bc-midazolam-oromucosal-solution-now-available-in-the-united-kingdom-as-licenced-product-for-emergency-treatment-of-seizures-in-children-and-adolescents-54648/" title="ViroPharma&#8217;s Buccolam®▼ (Midazolam, Oromucosal Solution) now Available in the United Kingdom as Licenced Product for Emergency Treatment of Seizures in Children and Adolescents">Gaea News Network</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/viropharmas-buccolam%c2%ae%e2%96%bc-midazolam-oromucosal-solution-now-available-in-the-united-kingdom-as-licenced-product-for-emergency-treatment-of-seizures-in-children-and-adolescents-54648/feed/</wfw:commentRss>
		</item>
		<item>
		<title>HealthpointCapital Acquires Blue Belt Technologies, Inc. and Appoints Eric B. Timko as President and CEO</title>
		<link>http://pr.gaeatimes.com/healthpointcapital-acquires-blue-belt-technologies-inc-and-appoints-eric-b-timko-as-president-and-ceo-54480/</link>
		<comments>http://pr.gaeatimes.com/healthpointcapital-acquires-blue-belt-technologies-inc-and-appoints-eric-b-timko-as-president-and-ceo-54480/#comments</comments>
		<pubDate>Wed, 07 Dec 2011 05:00:00 +0000</pubDate>
		<dc:creator>Healthpointcapital Llc</dc:creator>
		
		<category><![CDATA[Acquisitions / Mergers / Takeovers]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Personnel Announcements]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[December 7]]></category>

		<category><![CDATA[Healthpointcapital Llc]]></category>

		<category><![CDATA[New York]]></category>

		<category><![CDATA[New York And Pittsburgh]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/healthpointcapital-acquires-blue-belt-technologies-inc-and-appoints-eric-b-timko-as-president-and-ceo-54480/</guid>
		<description><![CDATA[NEW YORK and PITTSBURGH, December 7, 2011  -

HealthpointCapital, LLC (&#8221;HealthpointCapital&#8221;) announced today the purchase of Blue Belt Technologies, Inc. (&#8221;Blue Belt&#8221; or &#8220;Company&#8221;). Blue Belt is developing the next generation of &#8220;smart&#8221; surgical instruments for use initially in orthopedic procedures and then for other surgical specialties including neurosurgery and otolaryngology (&#8221;ENT&#8221;). Terms of the .... <a href="http://pr.gaeatimes.com/healthpointcapital-acquires-blue-belt-technologies-inc-and-appoints-eric-b-timko-as-president-and-ceo-54480/">Source article &nbsp;: HealthpointCapital Acquires Blue Belt Technologies, Inc. and Appoints Eric B. Timko as President and CEO</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/healthpointcapital-acquires-blue-belt-technologies-inc-and-appoints-eric-b-timko-as-president-and-ceo-54480/feed/</wfw:commentRss>
		</item>
		<item>
		<title>INetU Expands its Exclusive Gated Community Cloud into Europe</title>
		<link>http://pr.gaeatimes.com/inetu-expands-its-exclusive-gated-community-cloud-into-europe-54374/</link>
		<comments>http://pr.gaeatimes.com/inetu-expands-its-exclusive-gated-community-cloud-into-europe-54374/#comments</comments>
		<pubDate>Tue, 06 Dec 2011 05:00:00 +0000</pubDate>
		<dc:creator>Inetu</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Corporate Expansion]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Allentown]]></category>

		<category><![CDATA[December 6]]></category>

		<category><![CDATA[France]]></category>

		<category><![CDATA[Inetu]]></category>

		<category><![CDATA[Netherlands]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/inetu-expands-its-exclusive-gated-community-cloud-into-europe-54374/</guid>
		<description><![CDATA[ALLENTOWN, Pennsylvania, December 6, 2011  -

- Gated Community Cloud&#8482; is the first ever Business-Only Cloud Solution
Leading managed hosting provider INetU (www.inetu.net) has announced the expansion of its exclusive &#8220;Gated Community Cloud&#8482;&#8221; into Europe out of its Amsterdam data center. While this service had been available to clients worldwide out of INetU&#8217;s Allentown facility, Europe-based ... Read the original article on Gaea Times at  : <a href="http://pr.gaeatimes.com/inetu-expands-its-exclusive-gated-community-cloud-into-europe-54374/">INetU Expands its Exclusive Gated Community Cloud into Europe</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/inetu-expands-its-exclusive-gated-community-cloud-into-europe-54374/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Wolters Kluwer Health Acquires Leading Open Access STM Journal Publisher in India</title>
		<link>http://pr.gaeatimes.com/wolters-kluwer-health-acquires-leading-open-access-stm-journal-publisher-in-india-54303/</link>
		<comments>http://pr.gaeatimes.com/wolters-kluwer-health-acquires-leading-open-access-stm-journal-publisher-in-india-54303/#comments</comments>
		<pubDate>Mon, 05 Dec 2011 05:00:00 +0000</pubDate>
		<dc:creator>Wolters Kluwer Health</dc:creator>
		
		<category><![CDATA[Acquisitions / Mergers / Takeovers]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Media]]></category>

		<category><![CDATA[December 5]]></category>

		<category><![CDATA[India]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Philadelphia]]></category>

		<category><![CDATA[Wolters Kluwer Health]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/wolters-kluwer-health-acquires-leading-open-access-stm-journal-publisher-in-india-54303/</guid>
		<description><![CDATA[PHILADELPHIA, December 5, 2011  -


Acquisition Gives Wolters Kluwer Health Strong Foothold in Open Access Publishing Business
Wolters Kluwer Health today announced that it has acquired Medknow PVT Ltd., a leading Scientific, Technical &#38; Medical (STM) journal publishing operation headquartered in Mumbai, India and one of the largest open access publishers in the world. The acquisition expands Wolters Kluwer .... <a href="http://pr.gaeatimes.com/wolters-kluwer-health-acquires-leading-open-access-stm-journal-publisher-in-india-54303/">Read the original article &nbsp;: Wolters Kluwer Health Acquires Leading Open Access STM Journal Publisher in India</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/wolters-kluwer-health-acquires-leading-open-access-stm-journal-publisher-in-india-54303/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS</title>
		<link>http://pr.gaeatimes.com/mylan-receives-tentative-fda-approval-through-pepfar-for-first-heat-stable-fixed-dose-combination-of-atazanavir-sulfate-and-ritonavir-tablets-for-hivaids-54196/</link>
		<comments>http://pr.gaeatimes.com/mylan-receives-tentative-fda-approval-through-pepfar-for-first-heat-stable-fixed-dose-combination-of-atazanavir-sulfate-and-ritonavir-tablets-for-hivaids-54196/#comments</comments>
		<pubDate>Thu, 01 Dec 2011 05:00:00 +0000</pubDate>
		<dc:creator>Mylan Inc.</dc:creator>
		
		<category><![CDATA[FDA Approval]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[December 1]]></category>

		<category><![CDATA[Mylan Inc.]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Pittsburgh]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/mylan-receives-tentative-fda-approval-through-pepfar-for-first-heat-stable-fixed-dose-combination-of-atazanavir-sulfate-and-ritonavir-tablets-for-hivaids-54196/</guid>
		<description><![CDATA[PITTSBURGH, December 1, 2011  -


- Product also &#8216;prequalified&#8217; by WHO as a second-line treatment option -
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited (formerly Matrix Laboratories Limited) has received tentative approval from the U.S. Food and Drug Administration (FDA) through the President&#8217;s Emergency Plan for AIDS Relief (PEPFAR) for its .... Read the original article &nbsp;: <a href="http://pr.gaeatimes.com/mylan-receives-tentative-fda-approval-through-pepfar-for-first-heat-stable-fixed-dose-combination-of-atazanavir-sulfate-and-ritonavir-tablets-for-hivaids-54196/">Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/mylan-receives-tentative-fda-approval-through-pepfar-for-first-heat-stable-fixed-dose-combination-of-atazanavir-sulfate-and-ritonavir-tablets-for-hivaids-54196/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Shire Announces Strategic Partnership for ADHD Medicines in Japan With Shionogi &amp; Co., Ltd.</title>
		<link>http://pr.gaeatimes.com/shire-announces-strategic-partnership-for-adhd-medicines-in-japan-with-shionogi-co-ltd-53611/</link>
		<comments>http://pr.gaeatimes.com/shire-announces-strategic-partnership-for-adhd-medicines-in-japan-with-shionogi-co-ltd-53611/#comments</comments>
		<pubDate>Fri, 18 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Shire Plc</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Joint Ventures]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[November 18]]></category>

		<category><![CDATA[Nyon]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Shire Plc]]></category>

		<category><![CDATA[Switzerland]]></category>

		<category><![CDATA[Switzerland And Philadelphia]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/shire-announces-strategic-partnership-for-adhd-medicines-in-japan-with-shionogi-co-ltd-53611/</guid>
		<description><![CDATA[NYON, Switzerland and PHILADELPHIA, November 18, 2011  -

Shionogi and Shire to jointly develop and commercialize ADHD medicines in Japan  
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has entered into an agreement with Shionogi &#38; Co. Ltd. of Japan to co-develop and co-commercialize certain of Shire&#8217;s Attention Deficit .... Read the original article &nbsp;: <a href="http://pr.gaeatimes.com/shire-announces-strategic-partnership-for-adhd-medicines-in-japan-with-shionogi-co-ltd-53611/">here</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/shire-announces-strategic-partnership-for-adhd-medicines-in-japan-with-shionogi-co-ltd-53611/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Elsevier Announces Collaboration with ExitCare to Enhance Patient Education</title>
		<link>http://pr.gaeatimes.com/elsevier-announces-collaboration-with-exitcare-to-enhance-patient-education-53493/</link>
		<comments>http://pr.gaeatimes.com/elsevier-announces-collaboration-with-exitcare-to-enhance-patient-education-53493/#comments</comments>
		<pubDate>Wed, 16 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Elsevier</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Joint Ventures]]></category>

		<category><![CDATA[Media]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Elsevier]]></category>

		<category><![CDATA[November 16]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Philadelphia]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/elsevier-announces-collaboration-with-exitcare-to-enhance-patient-education-53493/</guid>
		<description><![CDATA[PHILADELPHIA, November 16, 2011  -

New relationship will expand patient education content provided through Elsevier&#8217;s online products; Mosby&#8217;s Nursing Consult and Mosby&#8217;s Nursing Skills are first to offer ExitCare content, Elsevier expects to integrate ExitCare content further into Elsevier products in the near future
Elsevier, a world-leading provider of scientific, technical and medical information products and  [..] <a href="http://pr.gaeatimes.com/elsevier-announces-collaboration-with-exitcare-to-enhance-patient-education-53493/">Read the original article: here</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/elsevier-announces-collaboration-with-exitcare-to-enhance-patient-education-53493/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Hamilton Lane Expands London Investment Team</title>
		<link>http://pr.gaeatimes.com/hamilton-lane-expands-london-investment-team-53520/</link>
		<comments>http://pr.gaeatimes.com/hamilton-lane-expands-london-investment-team-53520/#comments</comments>
		<pubDate>Wed, 16 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Hamilton Lane</dc:creator>
		
		<category><![CDATA[Banking and Financial Services]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Corporate Expansion]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Personnel Announcements]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Hamilton Lane]]></category>

		<category><![CDATA[November 16]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Philadelphia]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/hamilton-lane-expands-london-investment-team-53520/</guid>
		<description><![CDATA[PHILADELPHIA, November 16, 2011  -

Hamilton Lane, an independent financial institution that provides discretionary and non-discretionary private equity asset management services to sophisticated investors, today announced that it is expanding its London investment team with the addition of Jim Strang as Principal.
Strang joins the firm with over 10 years of experience investing in and consulting ... Read more <a href="http://pr.gaeatimes.com/hamilton-lane-expands-london-investment-team-53520/" title="Hamilton Lane Expands London Investment Team">&raquo;&raquo;&raquo;</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/hamilton-lane-expands-london-investment-team-53520/feed/</wfw:commentRss>
		</item>
		<item>
		<title>PEI-Genesis Value-Adds Power Supplies from Emerson Network Power for Delivery in Europe in Only 5 Days</title>
		<link>http://pr.gaeatimes.com/pei-genesis-value-adds-power-supplies-from-emerson-network-power-for-delivery-in-europe-in-only-5-days-53360/</link>
		<comments>http://pr.gaeatimes.com/pei-genesis-value-adds-power-supplies-from-emerson-network-power-for-delivery-in-europe-in-only-5-days-53360/#comments</comments>
		<pubDate>Tue, 15 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Pei-genesis Inc.</dc:creator>
		
		<category><![CDATA[Aerospace / Defense]]></category>

		<category><![CDATA[Auto and Transportation]]></category>

		<category><![CDATA[Electrical Utilities]]></category>

		<category><![CDATA[Energy]]></category>

		<category><![CDATA[Oil]]></category>

		<category><![CDATA[Utilities]]></category>

		<category><![CDATA[Europe]]></category>

		<category><![CDATA[November 15]]></category>

		<category><![CDATA[Pei-genesis Inc.]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Philadelphia]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/pei-genesis-value-adds-power-supplies-from-emerson-network-power-for-delivery-in-europe-in-only-5-days-53360/</guid>
		<description><![CDATA[PHILADELPHIA, November 15, 2011  -

PEI-Genesis, Inc., one of the world&#8217;s fastest integrators of configurable and modified standard power supplies, today announced an agreement with Emerson Network Power, a business of Emerson and the global leader in enabling Business-Critical Continuity&#8482;, in which PEI-Genesis will distribute and add value to power supply products from Emerson Network ... <a href="http://pr.gaeatimes.com/pei-genesis-value-adds-power-supplies-from-emerson-network-power-for-delivery-in-europe-in-only-5-days-53360/">Read more : PEI-Genesis Value-Adds Power Supplies from Emerson Network Power for Delivery in Europe in Only 5 Days</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/pei-genesis-value-adds-power-supplies-from-emerson-network-power-for-delivery-in-europe-in-only-5-days-53360/feed/</wfw:commentRss>
		</item>
		<item>
		<title>ViroPharma Completes Acquisition of DuoCort Pharma AB</title>
		<link>http://pr.gaeatimes.com/viropharma-completes-acquisition-of-duocort-pharma-ab-53413/</link>
		<comments>http://pr.gaeatimes.com/viropharma-completes-acquisition-of-duocort-pharma-ab-53413/#comments</comments>
		<pubDate>Tue, 15 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Viropharma Incorporated</dc:creator>
		
		<category><![CDATA[Acquisitions / Mergers / Takeovers]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Exton]]></category>

		<category><![CDATA[November 15]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[sweden]]></category>

		<category><![CDATA[Viropharma Incorporated]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/viropharma-completes-acquisition-of-duocort-pharma-ab-53413/</guid>
		<description><![CDATA[EXTON, Pennsylvania, November 15, 2011  -


- Completion Follows European Marketing Authorization and Confirmation of Orphan Drug Designation for Plenadren® (Hydrocortisone, Modified Release Tablet) -
ViroPharma Incorporated (NASDAQ: VPHM) today announced that it completed its acquisition of DuoCort Pharma AB, a private company based in Helsingborg, Sweden focused on improving glucocorticoid replacement therapy. The acquisition of .... <a href="http://pr.gaeatimes.com/viropharma-completes-acquisition-of-duocort-pharma-ab-53413/">Original article on Gaea Times at  &nbsp;: ViroPharma Completes Acquisition of DuoCort Pharma AB</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/viropharma-completes-acquisition-of-duocort-pharma-ab-53413/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Keryx Biopharmaceuticals Announces Highlights from Zerenex™ (ferric citrate) Poster Presentations at American Society of Nephrology Kidney Week 2011 Annual Meeting</title>
		<link>http://pr.gaeatimes.com/keryx-biopharmaceuticals-announces-highlights-from-zerenex%e2%84%a2-ferric-citrate-poster-presentations-at-american-society-of-nephrology-kidney-week-2011-annual-meeting-53341/</link>
		<comments>http://pr.gaeatimes.com/keryx-biopharmaceuticals-announces-highlights-from-zerenex%e2%84%a2-ferric-citrate-poster-presentations-at-american-society-of-nephrology-kidney-week-2011-annual-meeting-53341/#comments</comments>
		<pubDate>Mon, 14 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Keryx Biopharmaceuticals Inc.</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Trade Show]]></category>

		<category><![CDATA[Keryx Biopharmaceuticals Inc.]]></category>

		<category><![CDATA[New York]]></category>

		<category><![CDATA[November 14]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/keryx-biopharmaceuticals-announces-highlights-from-zerenex%e2%84%a2-ferric-citrate-poster-presentations-at-american-society-of-nephrology-kidney-week-2011-annual-meeting-53341/</guid>
		<description><![CDATA[NEW YORK, November 14, 2011  -

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that two posters highlighting potential cost savings based on observations from previous clinical trials of Zerenex&#8482; (ferric citrate) were presented by DaVita Clinical Research this past weekend during the American Society of Nephrology (ASN) Kidney Week 2011 Annual Meeting and Exposition in .... <a href="http://pr.gaeatimes.com/keryx-biopharmaceuticals-announces-highlights-from-zerenex%e2%84%a2-ferric-citrate-poster-presentations-at-american-society-of-nephrology-kidney-week-2011-annual-meeting-53341/">Source article &nbsp;: Keryx Biopharmaceuticals Announces Highlights from Zerenex™ (ferric citrate) Poster Presentations at American Society of Nephrology Kidney Week 2011 Annual Meeting</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/keryx-biopharmaceuticals-announces-highlights-from-zerenex%e2%84%a2-ferric-citrate-poster-presentations-at-american-society-of-nephrology-kidney-week-2011-annual-meeting-53341/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Sting &amp; @radical.media Launch The STING 25 App For iPad</title>
		<link>http://pr.gaeatimes.com/sting-radicalmedia-launch-the-sting-25-app-for-ipad-53358/</link>
		<comments>http://pr.gaeatimes.com/sting-radicalmedia-launch-the-sting-25-app-for-ipad-53358/#comments</comments>
		<pubDate>Mon, 14 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>@radical.media</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Entertainment]]></category>

		<category><![CDATA[Mobile Entertainment]]></category>

		<category><![CDATA[Multimedia / Online / Internet]]></category>

		<category><![CDATA[Music]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[@radical.media]]></category>

		<category><![CDATA[New York]]></category>

		<category><![CDATA[November 15]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/sting-radicalmedia-launch-the-sting-25-app-for-ipad-53358/</guid>
		<description><![CDATA[NEW YORK, November 15, 2011  -
- Now Available on iTunes

- An In-Depth, Digital Rendering of Sting&#8217;s Solo Career Featuring Exclusive All-Star Performances From His 60th Birthday Concert at New York City&#8217;s Beacon Theatre
Sting, in partnership with global transmedia company @radical.media, has launched STING 25. The expansive, dynamic app for iPad explores the life, music ... <a href="http://pr.gaeatimes.com/sting-radicalmedia-launch-the-sting-25-app-for-ipad-53358/">Read this article on Gaea Times at  : Sting &amp; @radical.media Launch The STING 25 App For iPad</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/sting-radicalmedia-launch-the-sting-25-app-for-ipad-53358/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting</title>
		<link>http://pr.gaeatimes.com/keryx-biopharmaceuticals-inc-announces-upcoming-poster-presentations-of-zerenex%e2%84%a2-ferric-citrate-at-the-upcoming-american-society-of-nephrology-kidney-week-2011-annual-meeting-53153/</link>
		<comments>http://pr.gaeatimes.com/keryx-biopharmaceuticals-inc-announces-upcoming-poster-presentations-of-zerenex%e2%84%a2-ferric-citrate-at-the-upcoming-american-society-of-nephrology-kidney-week-2011-annual-meeting-53153/#comments</comments>
		<pubDate>Wed, 09 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Keryx Biopharmaceuticals Inc.</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Trade Show]]></category>

		<category><![CDATA[Keryx Biopharmaceuticals Inc.]]></category>

		<category><![CDATA[New York]]></category>

		<category><![CDATA[November 9]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/keryx-biopharmaceuticals-inc-announces-upcoming-poster-presentations-of-zerenex%e2%84%a2-ferric-citrate-at-the-upcoming-american-society-of-nephrology-kidney-week-2011-annual-meeting-53153/</guid>
		<description><![CDATA[NEW YORK, November 9, 2011  -
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that two abstracts highlighting potential cost savings based on clinical observations from clinical trials of Zerenex&#8482; (ferric citrate) have been accepted for poster presentation at the upcoming American Society of Nephrology (ASN) Kidney Week 2011 Annual Meeting and exposition taking place November .... Original source &nbsp;: <a href="http://pr.gaeatimes.com/keryx-biopharmaceuticals-inc-announces-upcoming-poster-presentations-of-zerenex%e2%84%a2-ferric-citrate-at-the-upcoming-american-society-of-nephrology-kidney-week-2011-annual-meeting-53153/">Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/keryx-biopharmaceuticals-inc-announces-upcoming-poster-presentations-of-zerenex%e2%84%a2-ferric-citrate-at-the-upcoming-american-society-of-nephrology-kidney-week-2011-annual-meeting-53153/feed/</wfw:commentRss>
		</item>
		<item>
		<title>DuoCort Pharma&#8217;s Orphan Drug Plenadren® Granted European Marketing Authorization for Adrenal Insufficiency</title>
		<link>http://pr.gaeatimes.com/duocort-pharmas-orphan-drug-plenadren%c2%ae-granted-european-marketing-authorization-for-adrenal-insufficiency-52989/</link>
		<comments>http://pr.gaeatimes.com/duocort-pharmas-orphan-drug-plenadren%c2%ae-granted-european-marketing-authorization-for-adrenal-insufficiency-52989/#comments</comments>
		<pubDate>Mon, 07 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Duocort Pharma</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Duocort Pharma]]></category>

		<category><![CDATA[Helsingborg]]></category>

		<category><![CDATA[November 7]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[sweden]]></category>

		<category><![CDATA[Sweden And Exton]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/duocort-pharmas-orphan-drug-plenadren%c2%ae-granted-european-marketing-authorization-for-adrenal-insufficiency-52989/</guid>
		<description><![CDATA[HELSINGBORG, Sweden and EXTON, Pennsylvania, November 7, 2011  -


The Swedish specialty pharma company, DuoCort Pharma, announced today that the European Commission has granted a European Marketing Authorisation for Plenadren® (hydrocortisone, modified release tablet), an orphan drug for treatment of adrenal insufficiency in adults,  bringing these patients their first pharmaceutical innovation in over 50 years.
Developed by  [..] <a href="http://pr.gaeatimes.com/duocort-pharmas-orphan-drug-plenadren%c2%ae-granted-european-marketing-authorization-for-adrenal-insufficiency-52989/">Read the original article: here</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/duocort-pharmas-orphan-drug-plenadren%c2%ae-granted-european-marketing-authorization-for-adrenal-insufficiency-52989/feed/</wfw:commentRss>
		</item>
		<item>
		<title>L.B. Foster Reports Strong Third Quarter Operating Results</title>
		<link>http://pr.gaeatimes.com/lb-foster-reports-strong-third-quarter-operating-results-52692/</link>
		<comments>http://pr.gaeatimes.com/lb-foster-reports-strong-third-quarter-operating-results-52692/#comments</comments>
		<pubDate>Tue, 01 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>L.b. Foster Company</dc:creator>
		
		<category><![CDATA[Auto and Transportation]]></category>

		<category><![CDATA[Banking and Financial Services]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Conference Call Announcements]]></category>

		<category><![CDATA[Earnings]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Railroads and Intermodal Transportation]]></category>

		<category><![CDATA[Transportation / Trucking / Railroad]]></category>

		<category><![CDATA[L.b. Foster Company]]></category>

		<category><![CDATA[November 1]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Pittsburgh]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/lb-foster-reports-strong-third-quarter-operating-results-52692/</guid>
		<description><![CDATA[PITTSBURGH, November 1, 2011  -

L.B. Foster Company (NASDAQ: FSTR), a leading manufacturer, fabricator, and distributor of products and services for rail, construction, energy and utility markets, today reported its 2011 third quarter operating results.
(Logo: photos.prnewswire.com/prnh/20101222/MM21387LOGO )
Third Quarter Results

Third quarter net income was $9.7 million or $0.95 per diluted share compared to $6.5 million or .... Source &nbsp;: <a href="http://pr.gaeatimes.com/lb-foster-reports-strong-third-quarter-operating-results-52692/">L.B. Foster Reports Strong Third Quarter Operating Results</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/lb-foster-reports-strong-third-quarter-operating-results-52692/feed/</wfw:commentRss>
		</item>
		<item>
		<title>ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline</title>
		<link>http://pr.gaeatimes.com/viropharma-to-acquire-duocort-pharma-ab-adding-important-european-orphan-drug-to-commercial-pipeline-52503/</link>
		<comments>http://pr.gaeatimes.com/viropharma-to-acquire-duocort-pharma-ab-adding-important-european-orphan-drug-to-commercial-pipeline-52503/#comments</comments>
		<pubDate>Thu, 27 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>Viropharma Incorporated</dc:creator>
		
		<category><![CDATA[Acquisitions / Mergers / Takeovers]]></category>

		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Exton]]></category>

		<category><![CDATA[October 27]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Viropharma Incorporated]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/viropharma-to-acquire-duocort-pharma-ab-adding-important-european-orphan-drug-to-commercial-pipeline-52503/</guid>
		<description><![CDATA[EXTON, Pennsylvania, October 27, 2011  -

- Positive CHMP Opinion Adopted for Product to Treat Adrenal Insufficiency, an Orphan Disease with Limited Treatment Options -
ViroPharma Incorporated (NASDAQ: VPHM) today announced that it has signed a definitive agreement to acquire DuoCort Pharma AB, a private company based in Helsingborg, Sweden focused on improving glucocorticoid replacement therapy. ... <a href="http://pr.gaeatimes.com/viropharma-to-acquire-duocort-pharma-ab-adding-important-european-orphan-drug-to-commercial-pipeline-52503/">Original source on Gaea Times at  : ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/viropharma-to-acquire-duocort-pharma-ab-adding-important-european-orphan-drug-to-commercial-pipeline-52503/feed/</wfw:commentRss>
		</item>
		<item>
		<title>L.B. Foster Company to Report Third Quarter 2011 Operating Results on November 1</title>
		<link>http://pr.gaeatimes.com/lb-foster-company-to-report-third-quarter-2011-operating-results-on-november-1-52532/</link>
		<comments>http://pr.gaeatimes.com/lb-foster-company-to-report-third-quarter-2011-operating-results-on-november-1-52532/#comments</comments>
		<pubDate>Thu, 27 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>L.b. Foster Company</dc:creator>
		
		<category><![CDATA[Auto and Transportation]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Conference Call Announcements]]></category>

		<category><![CDATA[Construction / Building]]></category>

		<category><![CDATA[Energy]]></category>

		<category><![CDATA[Oil]]></category>

		<category><![CDATA[Railroads and Intermodal Transportation]]></category>

		<category><![CDATA[Transportation / Trucking / Railroad]]></category>

		<category><![CDATA[Utilities]]></category>

		<category><![CDATA[L.b. Foster Company]]></category>

		<category><![CDATA[October 27]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Pittsburgh]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/lb-foster-company-to-report-third-quarter-2011-operating-results-on-november-1-52532/</guid>
		<description><![CDATA[PITTSBURGH, October 27, 2011  -

L.B. Foster Company (Nasdaq: FSTR) today announced that it will broadcast a conference call to discuss its third quarter 2011 operating results on Tuesday, November 1, 2011 at 11:00 am Eastern Time.  The Company plans to release its results that same day before the market opens.  
(Logo:  photos.prnewswire.com/prnh/20101222/MM21387LOGO )
The call .... Original source &nbsp;: <a href="http://pr.gaeatimes.com/lb-foster-company-to-report-third-quarter-2011-operating-results-on-november-1-52532/">L.B. Foster Company to Report Third Quarter 2011 Operating Results on November 1</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/lb-foster-company-to-report-third-quarter-2011-operating-results-on-november-1-52532/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Informex Introduces a Thorough Global Pharma Perspectives Conference</title>
		<link>http://pr.gaeatimes.com/informex-introduces-a-thorough-global-pharma-perspectives-conference-52458/</link>
		<comments>http://pr.gaeatimes.com/informex-introduces-a-thorough-global-pharma-perspectives-conference-52458/#comments</comments>
		<pubDate>Wed, 26 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>Informex</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Chemical]]></category>

		<category><![CDATA[Conference Call Announcements]]></category>

		<category><![CDATA[Energy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Trade Show]]></category>

		<category><![CDATA[Informex]]></category>

		<category><![CDATA[new jersey]]></category>

		<category><![CDATA[October 26]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Princeton]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/informex-introduces-a-thorough-global-pharma-perspectives-conference-52458/</guid>
		<description><![CDATA[PRINCETON, New Jersey, October 26, 2011  -


Informex, the leading meeting place for buyers and sellers of high-value chemistry, today announced details of the Global Pharma Sourcing Conference to be held December 6-7, 2011 at the Hilton Philadelphia City Avenue in Philadelphia, Pennsylvania. The two day program will be jointly hosted by UBM Live brands ... <a href="http://pr.gaeatimes.com/informex-introduces-a-thorough-global-pharma-perspectives-conference-52458/">Read this article on Gaea Times at  : Informex Introduces a Thorough Global Pharma Perspectives Conference</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/informex-introduces-a-thorough-global-pharma-perspectives-conference-52458/feed/</wfw:commentRss>
		</item>
		<item>
		<title>L.B. Foster Company Declares Quarterly Dividend</title>
		<link>http://pr.gaeatimes.com/lb-foster-company-declares-quarterly-dividend-2-52464/</link>
		<comments>http://pr.gaeatimes.com/lb-foster-company-declares-quarterly-dividend-2-52464/#comments</comments>
		<pubDate>Wed, 26 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>L.b. Foster Company</dc:creator>
		
		<category><![CDATA[Auto and Transportation]]></category>

		<category><![CDATA[Dividends]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Machine Tools / Metalworking / Metallurgy]]></category>

		<category><![CDATA[Machinery]]></category>

		<category><![CDATA[Transportation / Trucking / Railroad]]></category>

		<category><![CDATA[L.b. Foster Company]]></category>

		<category><![CDATA[October 26]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Pittsburgh]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/lb-foster-company-declares-quarterly-dividend-2-52464/</guid>
		<description><![CDATA[PITTSBURGH, October 26, 2011  -

L.B. Foster Company (Nasdaq: FSTR) announced today that its Board of Directors has authorized a $0.025 per share quarterly cash dividend on its issued and outstanding shares of common stock, payable December 23, 2011 to shareholders of record at the close of business on December 9, 2011.  There are currently .... <a href="http://pr.gaeatimes.com/lb-foster-company-declares-quarterly-dividend-2-52464/">Original source &nbsp;: L.B. Foster Company Declares Quarterly Dividend</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/lb-foster-company-declares-quarterly-dividend-2-52464/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Be One of the First to Experience the New Medtrack Platform at BIO®-Europe 2011</title>
		<link>http://pr.gaeatimes.com/be-one-of-the-first-to-experience-the-new-medtrack-platform-at-bio%c2%ae-europe-2011-52175/</link>
		<comments>http://pr.gaeatimes.com/be-one-of-the-first-to-experience-the-new-medtrack-platform-at-bio%c2%ae-europe-2011-52175/#comments</comments>
		<pubDate>Thu, 20 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>Medtrack</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Trade Show]]></category>

		<category><![CDATA[Medtrack]]></category>

		<category><![CDATA[October 20]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Scranton]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/be-one-of-the-first-to-experience-the-new-medtrack-platform-at-bio%c2%ae-europe-2011-52175/</guid>
		<description><![CDATA[SCRANTON, Pennsylvania, October 20, 2011  -


- One View is the one stop solution for life science professionals seeking to make strategic business decisions.
Medtrack is pleased to announce we will debut One View at BIO-Europe 2011. Attendees of the show will be the first to have the opportunity to gain first-hand experience with the newly ... <a href="http://pr.gaeatimes.com/be-one-of-the-first-to-experience-the-new-medtrack-platform-at-bio%c2%ae-europe-2011-52175/">Original article on  : Be One of the First to Experience the New Medtrack Platform at BIO®-Europe 2011</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/be-one-of-the-first-to-experience-the-new-medtrack-platform-at-bio%c2%ae-europe-2011-52175/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Colorcon and BASF Announce Collaboration to Develop Film Coating Applications Using Kollicoat® Smartseal 30 D</title>
		<link>http://pr.gaeatimes.com/colorcon-and-basf-announce-collaboration-to-develop-film-coating-applications-using-kollicoat%c2%ae-smartseal-30-d-52202/</link>
		<comments>http://pr.gaeatimes.com/colorcon-and-basf-announce-collaboration-to-develop-film-coating-applications-using-kollicoat%c2%ae-smartseal-30-d-52202/#comments</comments>
		<pubDate>Thu, 20 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>Colorcon</dc:creator>
		
		<category><![CDATA[Chemical]]></category>

		<category><![CDATA[Energy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Joint Ventures]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Colorcon]]></category>

		<category><![CDATA[Germany]]></category>

		<category><![CDATA[Harleysville]]></category>

		<category><![CDATA[October 20]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Pennsylvania And Ludwigshafen]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/colorcon-and-basf-announce-collaboration-to-develop-film-coating-applications-using-kollicoat%c2%ae-smartseal-30-d-52202/</guid>
		<description><![CDATA[HARLEYSVILLE, Pennsylvania and LUDWIGSHAFEN, Germany, October 20, 2011  -

Colorcon, Inc. and BASF have announced a collaboration for the development of future film coating systems using Kollicoat® Smartseal 30 D, and a new Colorcon pre-formulated additive.
Colorcon has developed a pre-formulated additive system for use with Kollicoat Smartseal 30 D which enables efficient preparation and application ... Read more : <a href="http://pr.gaeatimes.com/colorcon-and-basf-announce-collaboration-to-develop-film-coating-applications-using-kollicoat%c2%ae-smartseal-30-d-52202/">Colorcon and BASF Announce Collaboration to Develop Film Coating Applications Using Kollicoat® Smartseal 30 D</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/colorcon-and-basf-announce-collaboration-to-develop-film-coating-applications-using-kollicoat%c2%ae-smartseal-30-d-52202/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Colorcon, Inc. Introduces Opadry® 200 Optimized Performance Film Coatings</title>
		<link>http://pr.gaeatimes.com/colorcon-inc-introduces-opadry%c2%ae-200-optimized-performance-film-coatings-52120/</link>
		<comments>http://pr.gaeatimes.com/colorcon-inc-introduces-opadry%c2%ae-200-optimized-performance-film-coatings-52120/#comments</comments>
		<pubDate>Wed, 19 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>Colorcon Inc.</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Trade Show]]></category>

		<category><![CDATA[Colorcon Inc.]]></category>

		<category><![CDATA[District of Columbia]]></category>

		<category><![CDATA[Germany]]></category>

		<category><![CDATA[Harleysville]]></category>

		<category><![CDATA[October 19]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/colorcon-inc-introduces-opadry%c2%ae-200-optimized-performance-film-coatings-52120/</guid>
		<description><![CDATA[HARLEYSVILLE, Pennsylvania, October 19, 2011  -


Colorcon, Inc. will introduce a new optimized performance film coating system, Opadry® 200, during the week of October 24, 2011 at both the American Association of Pharmaceutical Scientists Annual Meeting in Washington, D.C. (Booth #2237) and the CPhI Worldwide Event in Frankfurt, Germany (Stand #42J05).  Opadry 200 represents Colorcon&#8217;s .... Read the original article &nbsp;: <a href="http://pr.gaeatimes.com/colorcon-inc-introduces-opadry%c2%ae-200-optimized-performance-film-coatings-52120/">Colorcon, Inc. Introduces Opadry® 200 Optimized Performance Film Coatings</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/colorcon-inc-introduces-opadry%c2%ae-200-optimized-performance-film-coatings-52120/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Charming Shoppes Goes Global Online</title>
		<link>http://pr.gaeatimes.com/charming-shoppes-goes-global-online-52052/</link>
		<comments>http://pr.gaeatimes.com/charming-shoppes-goes-global-online-52052/#comments</comments>
		<pubDate>Tue, 18 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>Charming Shoppes Inc.</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Consumer Products]]></category>

		<category><![CDATA[Corporate Expansion]]></category>

		<category><![CDATA[Fashion]]></category>

		<category><![CDATA[Multicultural]]></category>

		<category><![CDATA[Retail]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Women Related]]></category>

		<category><![CDATA[Bensalem]]></category>

		<category><![CDATA[Charming Shoppes Inc.]]></category>

		<category><![CDATA[October 18]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/charming-shoppes-goes-global-online-52052/</guid>
		<description><![CDATA[BENSALEM, Pennsylvania, October 18, 2011  -


- Brings Leading Plus Size Fashion Brands to Women Around the World
Charming Shoppes, Inc., the leading women&#8217;s specialty plus size retailer in the U.S., (NASDAQ: CHRS) is pleased to announce that today, for the first time, consumers shopping for plus sizes around the globe will have online access to .... Source article &nbsp;: <a href="http://pr.gaeatimes.com/charming-shoppes-goes-global-online-52052/">Charming Shoppes Goes Global Online</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/charming-shoppes-goes-global-online-52052/feed/</wfw:commentRss>
		</item>
		<item>
		<title>FMC Corporation Completes Acquisition of RheinPerChemie European Persulfates Business</title>
		<link>http://pr.gaeatimes.com/fmc-corporation-completes-acquisition-of-rheinperchemie-european-persulfates-business-51496/</link>
		<comments>http://pr.gaeatimes.com/fmc-corporation-completes-acquisition-of-rheinperchemie-european-persulfates-business-51496/#comments</comments>
		<pubDate>Thu, 06 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>Fmc Corporation</dc:creator>
		
		<category><![CDATA[Acquisitions / Mergers / Takeovers]]></category>

		<category><![CDATA[Agriculture]]></category>

		<category><![CDATA[Chemical]]></category>

		<category><![CDATA[Energy]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Fmc Corporation]]></category>

		<category><![CDATA[Germany]]></category>

		<category><![CDATA[October 6]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Philadelphia]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/fmc-corporation-completes-acquisition-of-rheinperchemie-european-persulfates-business-51496/</guid>
		<description><![CDATA[PHILADELPHIA, October 6, 2011  -

FMC Corporation (NYSE: FMC) announced today the company has completed its acquisition of the European persulfates business of RheinPerChemie GmbH from Unionchimica SpA.  The acquisition strengthens FMC Peroxygens&#8217; global reach and immediately broadens the company&#8217;s product portfolio for Europe, the Middle East and Africa.  
&#8220;This is an excellent business that ... Read the original article on Gaea Times at  : <a href="http://pr.gaeatimes.com/fmc-corporation-completes-acquisition-of-rheinperchemie-european-persulfates-business-51496/">FMC Corporation Completes Acquisition of RheinPerChemie European Persulfates Business</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/fmc-corporation-completes-acquisition-of-rheinperchemie-european-persulfates-business-51496/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teleos Leadership Institute Announces Dates for the Next Teleos Coach Development Program in Philadelphia, PA</title>
		<link>http://pr.gaeatimes.com/teleos-leadership-institute-announces-dates-for-the-next-teleos-coach-development-program-in-philadelphia-pa-51512/</link>
		<comments>http://pr.gaeatimes.com/teleos-leadership-institute-announces-dates-for-the-next-teleos-coach-development-program-in-philadelphia-pa-51512/#comments</comments>
		<pubDate>Thu, 06 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>Teleos Leadership Institute</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Education]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Workforce Management / Human Resources]]></category>

		<category><![CDATA[Germany]]></category>

		<category><![CDATA[Italy]]></category>

		<category><![CDATA[October 6]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Philadelphia]]></category>

		<category><![CDATA[Teleos Leadership Institute]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/teleos-leadership-institute-announces-dates-for-the-next-teleos-coach-development-program-in-philadelphia-pa-51512/</guid>
		<description><![CDATA[PHILADELPHIA, October 6, 2011  -


- Teleos delivers fully ICF-accredited professional coach development program
The next US Teleos Coach Development Program (TCDP) will be offered Nov 14-19, 2011 and April 23-28, 2012; the next Europe TCDP and in Germany/Italy September 10-15, 2012 and March 18-23, 2013.
The Teleos Coach Development Program is a 12 day residential program, ... Read more : <a href="http://pr.gaeatimes.com/teleos-leadership-institute-announces-dates-for-the-next-teleos-coach-development-program-in-philadelphia-pa-51512/">Teleos Leadership Institute Announces Dates for the Next Teleos Coach Development Program in Philadelphia, PA</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teleos-leadership-institute-announces-dates-for-the-next-teleos-coach-development-program-in-philadelphia-pa-51512/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Albensi Labs Turnaround Time on Dental Restorations Drops from Seven Days to Just Two Days Using Objet 3D Printing</title>
		<link>http://pr.gaeatimes.com/albensi-labs-turnaround-time-on-dental-restorations-drops-from-seven-days-to-just-two-days-using-objet-3d-printing-51276/</link>
		<comments>http://pr.gaeatimes.com/albensi-labs-turnaround-time-on-dental-restorations-drops-from-seven-days-to-just-two-days-using-objet-3d-printing-51276/#comments</comments>
		<pubDate>Mon, 03 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>Objet Ltd</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Consumer Products]]></category>

		<category><![CDATA[Cosmetics and Personal Care]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Israel]]></category>

		<category><![CDATA[Objet Ltd]]></category>

		<category><![CDATA[October 3]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Rehovot]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/albensi-labs-turnaround-time-on-dental-restorations-drops-from-seven-days-to-just-two-days-using-objet-3d-printing-51276/</guid>
		<description><![CDATA[REHOVOT, Israel, October 3, 2011  -

Objet 3D Printer Digitizes Dentistry for Albensi Labs
It&#8217;s easy to think that perfectly restored teeth should simply be &#8220;a perfect set of pearly whites&#8221;. After all, aren&#8217;t all teeth bright white and regularly shaped? Far from it. In fact, creating precise dental restorations that look and fit like natural ... <a href="http://pr.gaeatimes.com/albensi-labs-turnaround-time-on-dental-restorations-drops-from-seven-days-to-just-two-days-using-objet-3d-printing-51276/">Original source on Gaea Times at  : Albensi Labs Turnaround Time on Dental Restorations Drops from Seven Days to Just Two Days Using Objet 3D Printing</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/albensi-labs-turnaround-time-on-dental-restorations-drops-from-seven-days-to-just-two-days-using-objet-3d-printing-51276/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Braskem Solidifies Its U.S. Polypropylene Leadership and Global Expansion Efforts</title>
		<link>http://pr.gaeatimes.com/braskem-solidifies-its-us-polypropylene-leadership-and-global-expansion-efforts-51213/</link>
		<comments>http://pr.gaeatimes.com/braskem-solidifies-its-us-polypropylene-leadership-and-global-expansion-efforts-51213/#comments</comments>
		<pubDate>Fri, 30 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Braskem S.a.</dc:creator>
		
		<category><![CDATA[Acquisitions / Mergers / Takeovers]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Chemical]]></category>

		<category><![CDATA[Corporate Expansion]]></category>

		<category><![CDATA[Energy]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[BRASKEM S.A.]]></category>

		<category><![CDATA[Brazil]]></category>

		<category><![CDATA[Germany]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Sao paulo]]></category>

		<category><![CDATA[September 30]]></category>

		<category><![CDATA[texas]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/braskem-solidifies-its-us-polypropylene-leadership-and-global-expansion-efforts-51213/</guid>
		<description><![CDATA[SAO PAULO, September 30, 2011  -


- The company completes its acquisition of The Dow Chemical Company Polypropylene Business; builds its global polypropylene capacity to four (4) million tons per year.
Braskem, the leading resin producer in the Americas, announced the completion of its acquisition of the Polypropylene Business from The Dow Chemical Company, an important ... <a href="http://pr.gaeatimes.com/braskem-solidifies-its-us-polypropylene-leadership-and-global-expansion-efforts-51213/">Read the original article on Gaea Times at  : Braskem Solidifies Its U.S. Polypropylene Leadership and Global Expansion Efforts</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/braskem-solidifies-its-us-polypropylene-leadership-and-global-expansion-efforts-51213/feed/</wfw:commentRss>
		</item>
		<item>
		<title>EnerSys to Launch a Joint Venture in South Africa</title>
		<link>http://pr.gaeatimes.com/enersys-to-launch-a-joint-venture-in-south-africa-51161/</link>
		<comments>http://pr.gaeatimes.com/enersys-to-launch-a-joint-venture-in-south-africa-51161/#comments</comments>
		<pubDate>Thu, 29 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Enersys</dc:creator>
		
		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Joint Ventures]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[EnerSys]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[Reading]]></category>

		<category><![CDATA[September 29]]></category>

		<category><![CDATA[South Africa]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/enersys-to-launch-a-joint-venture-in-south-africa-51161/</guid>
		<description><![CDATA[READING, Pennsylvania, September 29, 2011  -

EnerSys (NYSE: ENS), the global leader in stored energy solutions for industrial applications, announced today that it has entered into a definitive agreement to launch a joint venture in South Africa to produce and market batteries for industrial applications.
EnerSys will have majority ownership in the joint venture in cooperation ... Original source on Gaea Times at  : <a href="http://pr.gaeatimes.com/enersys-to-launch-a-joint-venture-in-south-africa-51161/">EnerSys to Launch a Joint Venture in South Africa</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/enersys-to-launch-a-joint-venture-in-south-africa-51161/feed/</wfw:commentRss>
		</item>
		<item>
		<title>You&#8217;re just older. You&#8217;re not dead. That is the message from TSN&#8217;s CEO &amp; President</title>
		<link>http://pr.gaeatimes.com/youre-just-older-youre-not-dead-that-is-the-message-from-tsns-ceo-president-51044/</link>
		<comments>http://pr.gaeatimes.com/youre-just-older-youre-not-dead-that-is-the-message-from-tsns-ceo-president-51044/#comments</comments>
		<pubDate>Wed, 28 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>The Sports Network</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Media]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Sports]]></category>

		<category><![CDATA[Hatboro]]></category>

		<category><![CDATA[Pennsylvania]]></category>

		<category><![CDATA[September 28]]></category>

		<category><![CDATA[The Sports Network]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/youre-just-older-youre-not-dead-that-is-the-message-from-tsns-ceo-president-51044/</guid>
		<description><![CDATA[HATBORO, Pennsylvania, September 28, 2011  -


The Sports Network (TSN) - It was announced today by The Sports Network, the nation&#8217;s premiere real-time source and wire service for sports content, that their CEO and President, Mickey Charles, and his wife, Rosalind, Vice President of the world-wide organization, have launched a new effort directed at the .... Read the original article &nbsp;: <a href="http://pr.gaeatimes.com/youre-just-older-youre-not-dead-that-is-the-message-from-tsns-ceo-president-51044/">You&#8217;re just older. You&#8217;re not dead. That is the message from TSN&#8217;s CEO &amp; President</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/youre-just-older-youre-not-dead-that-is-the-message-from-tsns-ceo-president-51044/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>

